The global healthcare mobility solutions market is expected to reach US$ 272,054 million by 2027 from US$ 57,162.65 million in 2019. It is estimated to grow at a CAGR of 22.2% from 2020 to 2027.
Mobile devices have become significant enablers of healthcare IT, and they are widely being used by healthcare providers as the most convenient means to treat patients, as well as to monitor their progress.Since the initiation of digital healthcare, there has been increased use of mobile devices.
According to a study conducted by Ponemon Institute in 2013, ~84% of the physicians had started using smartphones to fulfill their professional needs, whereas ~56% doctors use tablets for at work. Similarly, according to the GSMA real-time intelligence data, more than 5.13 billion people, accounting for 66.53% of the world population, owned mobile devices in 2019, and 50% of the 5.13 billion people (including, adults, and elderly people) are expected have mHealth apps installed in their smart mobile devices for tracking their fitness and vital health signs. These apps have also helped people in managing their medications and conditions. Further, the use of mobile devices has increased tenfold amid the COVID-19 pandemic, which has propelled various companies to diversify their capabilities and offer digital solutions for better medical workflows.Clinicians and physicians can use mobile devices and access tools to diagnose patients’ conditions in the ICUs or emergency settings.
This supports the smooth workflow, which has been boosting the demand for mobility solutions having installed in mobile devices during the COVID-19 pandemic.Mobile devices such as smartphones, tablets, and laptops enable first-line communication between staff and facility centers in a healthcare organization.
In addition, the electronic health records, (EHRs), clinical decision support systems (CDSS), and picture archiving communication systems (PACS) are widely preferred as the point of care through mobile devices.Similarly, clinicians are using mobile devices to access other medical resources of point-of-care such as drug references, clinical care guidelines, and medical calculators.
Moreover, the mobile monitoring devices used as the Internet of Things (IoT) help collect and share of the patients’ health data (PGHD) through telemedicine apps. Thus, on the back of various advantages, there has been a boost in the use of medical devices in the healthcare sector, which is eventually fueling the adoption of healthcare mobility solutions.
Based on products and services, the healthcare mobility solutions market is segmented into mobile devices, mobile applications, and enterprise mobility platforms.In 2019, the mobile devices segment accounted for the largest market share and it is estimated to dominate the market with the highest CAGR during the forecast period.
The growth of the market is attributed to the growing developments in medical device technology, which is integrated with information technology. Increasing digitalization and rising adoption of automated medical devices are likely to foster the market growth during 2020–2027.
Based on application, the healthcare mobility solutions market is segmented into enterprise solutions, and mHealth applications. The enterprise solutions segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Based on end user, the healthcare mobility solutions market is bifurcated into healthcare providers, healthcare payers, and patients. The healthcare providers held the largest share of the market in 2019, also the same segment is estimated to register the highest CAGR in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the healthcare mobility solutions market are Centers for Disease Control and Prevention, US Food and Drug Administration, National Health Security Administration, Government’s Department of Health and Social Care, and Ministry of Health in Argentina.
Our reports have been used by over 10K customers, including:
Urinalysis market is expected to exibhit a growth of 7.5% CAGR during the forecast period. The higher burden of chronic diseases and rising adaptation of point of care testing is expected to be the major contributing factors for the market growth. Urinary tract infection refers to the infection in any part of the urinary system. According...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
Executive Summary The Global Injectable Drugs Market was valued at USD 414.88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheumatoid arthritis and multiple sclerosis with an upsurge in the number of chronic diseases have driven the need for drug delivery...
The Middle East and Africa Artificial Intelligence (AI) in healthcare market is expected to reach US$ 5,713.28 million by 2027 from US$ 222.03 million in 2019; it is estimated to grow at a CAGR of 48.8% from 2020 to 2027. The growth of the market is attributed to the driving factors such as rising application of artificial intelligence (AI)...
The global post-COVID-19 CCM market size is forecasted to grow from USD 1.3 billion in 2021 to USD 2.2 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period. The major growth drivers for the market include increasing adoption of CCM solutions and services in various verticals such as IT and telecom, retail...
256 pages •
By The Business Research Company
• Mar 2021
Non-Contact Infrared Thermometers Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global non-contact infrared thermometers market as it emerges from the COVID 19 shut down. Description: Where...
The global queue management system(QMS) market size to grow from USD 0.5 billion in 2020 to USD 0.6 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period. Factors such as the increasing need to manage customer traffic and customer movement to boost productivity and the rising need to improve staff efficiency...
296 pages •
By The Business Research Company
• Mar 2021
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global vascular endothelial growth factor (VEGF) inhibitor market. Description: Where...
The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.12% during 2020-2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidences of cardiovascular diseases and growing adoption of tele-cardiac...
The medical second opinion market was valued at US$ 3,204.57 million in 2019 and is projected to reach US$ 10,739.48 million by 2027; it is expected to grow at a CAGR of 16.32% during 2020-2028. The growth of the medical second opinion market is mainly attributed to the increasing prevalence of chronic diseases, growing emphasis on superior...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.